Cargando…

Comparison of the 2021 COVID-19 roadmap projections against public health data in England

Control and mitigation of the COVID-19 pandemic in England has relied on a combination of vaccination and non-pharmaceutical interventions (NPIs). Some of these NPIs are extremely costly (economically and socially), so it was important to relax these promptly without overwhelming already burdened he...

Descripción completa

Detalles Bibliográficos
Autores principales: Keeling, Matt J., Dyson, Louise, Tildesley, Michael J., Hill, Edward M., Moore, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395530/
https://www.ncbi.nlm.nih.gov/pubmed/35995764
http://dx.doi.org/10.1038/s41467-022-31991-0
_version_ 1784771715664969728
author Keeling, Matt J.
Dyson, Louise
Tildesley, Michael J.
Hill, Edward M.
Moore, Samuel
author_facet Keeling, Matt J.
Dyson, Louise
Tildesley, Michael J.
Hill, Edward M.
Moore, Samuel
author_sort Keeling, Matt J.
collection PubMed
description Control and mitigation of the COVID-19 pandemic in England has relied on a combination of vaccination and non-pharmaceutical interventions (NPIs). Some of these NPIs are extremely costly (economically and socially), so it was important to relax these promptly without overwhelming already burdened health services. The eventual policy was a Roadmap of four relaxation steps throughout 2021, taking England from lock-down to the cessation of all restrictions on social interaction. In a series of six Roadmap documents generated throughout 2021, models assessed the potential risk of each relaxation step. Here we show that the model projections generated a reliable estimation of medium-term hospital admission trends, with the data points up to September 2021 generally lying within our 95% prediction intervals. The greatest uncertainties in the modelled scenarios came from vaccine efficacy estimates against novel variants, and from assumptions about human behaviour in the face of changing restrictions and risk.
format Online
Article
Text
id pubmed-9395530
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-93955302022-08-23 Comparison of the 2021 COVID-19 roadmap projections against public health data in England Keeling, Matt J. Dyson, Louise Tildesley, Michael J. Hill, Edward M. Moore, Samuel Nat Commun Article Control and mitigation of the COVID-19 pandemic in England has relied on a combination of vaccination and non-pharmaceutical interventions (NPIs). Some of these NPIs are extremely costly (economically and socially), so it was important to relax these promptly without overwhelming already burdened health services. The eventual policy was a Roadmap of four relaxation steps throughout 2021, taking England from lock-down to the cessation of all restrictions on social interaction. In a series of six Roadmap documents generated throughout 2021, models assessed the potential risk of each relaxation step. Here we show that the model projections generated a reliable estimation of medium-term hospital admission trends, with the data points up to September 2021 generally lying within our 95% prediction intervals. The greatest uncertainties in the modelled scenarios came from vaccine efficacy estimates against novel variants, and from assumptions about human behaviour in the face of changing restrictions and risk. Nature Publishing Group UK 2022-08-22 /pmc/articles/PMC9395530/ /pubmed/35995764 http://dx.doi.org/10.1038/s41467-022-31991-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Keeling, Matt J.
Dyson, Louise
Tildesley, Michael J.
Hill, Edward M.
Moore, Samuel
Comparison of the 2021 COVID-19 roadmap projections against public health data in England
title Comparison of the 2021 COVID-19 roadmap projections against public health data in England
title_full Comparison of the 2021 COVID-19 roadmap projections against public health data in England
title_fullStr Comparison of the 2021 COVID-19 roadmap projections against public health data in England
title_full_unstemmed Comparison of the 2021 COVID-19 roadmap projections against public health data in England
title_short Comparison of the 2021 COVID-19 roadmap projections against public health data in England
title_sort comparison of the 2021 covid-19 roadmap projections against public health data in england
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395530/
https://www.ncbi.nlm.nih.gov/pubmed/35995764
http://dx.doi.org/10.1038/s41467-022-31991-0
work_keys_str_mv AT keelingmattj comparisonofthe2021covid19roadmapprojectionsagainstpublichealthdatainengland
AT dysonlouise comparisonofthe2021covid19roadmapprojectionsagainstpublichealthdatainengland
AT tildesleymichaelj comparisonofthe2021covid19roadmapprojectionsagainstpublichealthdatainengland
AT hilledwardm comparisonofthe2021covid19roadmapprojectionsagainstpublichealthdatainengland
AT mooresamuel comparisonofthe2021covid19roadmapprojectionsagainstpublichealthdatainengland